Privia Health Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Privia Health Group generated cash of $80,785,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,705,000 last year. Net change in cash is therefore $41,519,000.
Cash Flow
| 2018 | 5.24M | -165K | 15.35M |
|---|---|---|---|
| 2019 | 24.35M | -5.70M | -10.86M |
| 2020 | 38.89M | -380K | -767K |
| 2021 | 55.05M | -32.77M | 213.66M |
| 2022 | 47.19M | -104K | -19.67M |
| 2023 | 80.78M | -42.97M | 3.70M |
PRVA Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 347.99M | 320.57M | 84.63M | 46.88M | 39.10M | 18.66M |
Operating activities | ||||||
Net income | 23.07M | -12.06M | -190.64M | 30.90M | 7.94M | -4.18M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 6.53M | 4.57M | 2.46M | 1.83M | 1.42M | 1.07M |
Stock-based compensation expense | 37.09M | 67.35M | 253.53M | 484K | 207K | 0 |
| Deferred income tax benefit | 37.09M | 67.35M | 253.53M | 484K | 207K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -96.87M | -72.20M | -14.64M | -21.77M | -6.17M | 320K |
Inventories | 0 | 0 | -1.26M | 0 | 0 | 0 |
Accounts payable | 4.99M | 6.85M | 1.26M | 4.71M | -4.14M | -983K |
Cash generated by operating activities | 80.78M | 47.19M | 55.05M | 38.89M | 24.35M | 5.24M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -113K | -104K | -547K | -380K | -5.70M | -220K |
Acquisitions Net | -42.85M | 125K | -32.22M | 0 | 0 | 55K |
Cash generated by investing activities | -42.97M | -104K | -32.77M | -380K | -5.70M | -165K |
Financing activities | ||||||
Common Stock Issued | 8.74M | 13.44M | 214.82M | 108K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -33.25M | -875K | -10.87M | -10.86M | 0 |
Cash used in financing activities | 3.70M | -19.67M | 213.66M | -767K | -10.86M | 15.35M |
Net Change In Cash | 41.51M | 27.41M | 235.94M | 37.74M | 7.78M | 20.44M |
Cash at end of period | 389.51M | 347.99M | 320.57M | 84.63M | 46.88M | 39.10M |
| Data source | Data source | Data source |